Sight Sciences (SGHT) Net Cash Flow Growth (3y) (2023 - 2026)
Sight Sciences (SGHT) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -48.90% |
| 10 | Sight Sciences | 277.27 Mn | 192.31 Mn | 16.98 Mn | 26.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.55% |
| Dec 31, 2025 | 69.85% |
| Sep 30, 2025 | 24.11% |
| Jun 30, 2025 | 26.75% |
| Mar 31, 2025 | 19.36% |
| Dec 31, 2024 | 29.39% |
| Sep 30, 2024 | -88.21% |
| Jun 30, 2024 | 10.62% |
| Mar 31, 2024 | 6.30% |
| Dec 31, 2023 | -29.74% |
| Sep 30, 2023 | -3.99% |